549PIMPACT OF TUMOUR RAS/BRAF STATUS ON EFFICACY OF FIRST-LINE PANITUMUMAB + FOLFIRI IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC).